Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
17 Jul 2024
Reply
17 Dec 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
USP
ANALYTICAL
ABOUT THIS PAGE
A Dihydroartemisinin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydroartemisinin, including repackagers and relabelers. The FDA regulates Dihydroartemisinin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydroartemisinin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydroartemisinin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydroartemisinin supplier is an individual or a company that provides Dihydroartemisinin active pharmaceutical ingredient (API) or Dihydroartemisinin finished formulations upon request. The Dihydroartemisinin suppliers may include Dihydroartemisinin API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydroartemisinin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dihydroartemisinin written confirmation (Dihydroartemisinin WC) is an official document issued by a regulatory agency to a Dihydroartemisinin manufacturer, verifying that the manufacturing facility of a Dihydroartemisinin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dihydroartemisinin APIs or Dihydroartemisinin finished pharmaceutical products to another nation, regulatory agencies frequently require a Dihydroartemisinin WC (written confirmation) as part of the regulatory process.
click here to find a list of Dihydroartemisinin suppliers with Written Confirmation (WC) on PharmaCompass.
Dihydroartemisinin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihydroartemisinin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydroartemisinin GMP manufacturer or Dihydroartemisinin GMP API supplier for your needs.
A Dihydroartemisinin CoA (Certificate of Analysis) is a formal document that attests to Dihydroartemisinin's compliance with Dihydroartemisinin specifications and serves as a tool for batch-level quality control.
Dihydroartemisinin CoA mostly includes findings from lab analyses of a specific batch. For each Dihydroartemisinin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihydroartemisinin may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydroartemisinin EP), Dihydroartemisinin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydroartemisinin USP).
LOOKING FOR A SUPPLIER?
Comment (2)
